Industry experts to serve as conference advisory group.
The INTERPHEX Conference Advisory Group, a diverse pool of individuals whose experience and expertise cover the entire pharmaceutical manufacturing process, were chosen on the basis of their outstanding accomplishments and high standing in the pharmaceutical manufacturing community.
As the "eyes and ears" of the industry, these dedicated experts provide insight into the industry's most pressing needs and the intellectual capital for science-based manufacturing innovation that will be presented at INTERPHEX. We are certain that with their input, the INTERPHEX2007 Conference program will be thought provoking, innovative, and a "must attend." Members of the Conference Advisory Board are:
Jerry C. Arthur of Cook Pharmica began his career in engineering at Eli Lilly and Company and by 1997 became president of Cook Pharmaceutical Solutions (CPS), a contract manufacturer organization providing sterile parenterals to the pharmaceutical and biotech industries. Under his leadership the company grew from 60 employees to more than 300 in 2001, when it was sold to Baxter. After transitioning the company to Baxter, Mr. Arthur began discussions with Cook to plan a new company, Cook Pharmica, which was formed in 2004.
Garry Bandel retired from Abbott Laboratories with thirty-two years of experience in manufacturing and quality assurance in the pharmaceutical industry. He was the head of quality assurance for four manufacturing facilities in three states in two divisions of Abbott Labs, and had no product recalls or warning letters at these facilities during his tenure. At the division level, Mr. Bandel developed polices and implemented programs that supported plant operations in the Pharmaceutical and Hospital Products Divisions.
Angelo DePalma holds a doctorate in chemistry from the State University of New York at Stony Brook. He served a post-doctoral fellowship at the Brookhaven National Laboratory and as a senior scientist with Schering-Plough Pharmaceuticals. Mr. DePalma has a distinguished career as a writer and editor in the life science industries, including medical, healthcare, medical device, diagnostics, veterinary, pharmaceutical, chemical, and biotechnology.
The career of William Garvey of Millipore Corporation, spans more than 25 years of pharmaceutical industry experience with employers including Fluor Daniel, Biogen, the radiopharmaceutical division of Dupont-Merck, Pfizer and Process Facilities, Inc. He has worked in a variety of product categories, including parenterals, solid oral dosage forms, biologics/vaccines, and APIs. His experience is equally divided between GMP/QA and validation, and he has successfully managed numerous validation projects.
Brian H. Lange, P.E. is Director of Sterile & Packaging Operations Engineering at Merck & Co., Inc. in West Point, Pennsylvania, where his responsibilities include facility, utility and maintenance support for barrier, liquid and lyo manufacturing, packaging operations and capital project execution. Previously, he managed operations for vaccine and pharmaceutical production, and also provided long-range planning and engineering support to all facets of research including facilities, solid and sterile clinical manufacturing and utility generation and distribution. Mr. Lange, also served as Chairman of the ISPE International Board of Directors from 2002-2003 and is a past President of the Delaware Valley Chapter.
Clive Mullins is the leader of Foster Wheeler's global pharmaceutical, biotechnology and healthcare business line. A graduate of Exeter University with a degree in chemical engineering, he has worked in the engineering and construction industry for 36 years. For the last 26 years he has focused exclusively on the pharmaceutical, biotechnology and healthcare industries, accumulating extensive experience in design, construction management, sales, marketing and team leadership.
Jaspreet Singh Sidhu, Ph.D. currently serves as Vice President of Business Development at Molecular Epidemiology, Inc. in Lake Forest Park, Washington. Prior to joining Molecular Epidemiology, Dr. Sidhu was Principal Scientist/Laboratory Research Director, University of Washington, Seattle, WA, where he also did his Post-Doctoral Fellowship. Dr. Sidhu has published in a number of fields, including gene expression, pharmacogenetics, toxicology, and molecular cell biochemistry. He has authored numerous scientific publications and is frequently invited to speak at seminars and symposia presentations.
Robert J. Timko is a Director in the Chemistry, Manufacturing and Controls Group of the Drug Regulatory Affairs Department of AstraZeneca LP. Dr. Timko has also served as the Team Director, Oncology Therapeutic Area, in the Global Regulatory Affairs Chemistry, Manufacturing anFd Controls Group. Previously, Dr. Timko was a Section Manager in the Product and Analytical Development Department, where he was responsible for various phases of the drug development process including drug discovery support, physical pharmacy, formulation and process development and scale-up, clinical supply manufacture, and facilities support.
INTERPHEX2007 will take place April 24-26, 2007 at the Jacob K. Javits Convention Center in New York City. For complete conference and event details and convenient online registration, please visit www.interphex.com.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||INTERPHEX 2007 Update|
|Date:||Oct 1, 2006|
|Previous Article:||Harnessing the power of desiccant technology for inhalation therapies: as new drugs come to market as inhalation therapies, manufacturers need to...|
|Next Article:||Roller curve conveyor provides non-contact conveying around virtually any degree curve.|